Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.
Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.
Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo
New insights into signaling during myelination in zebrafish.
Pharmacokinetics of CAMPATH-1H in BMT patients.
Alemtuzumab
Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing-Remitting Multiple Sclerosis.
Trimesta in relapsing-remitting multiple sclerosis patients (Phase II)
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies.
ARESTIN®
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Refining diagnosis of multiple sclerosis with revised MRI criteria.
Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases.
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
B cells and multiple sclerosis.
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
The interplay between the intestinal microbiota and the brain.
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
lambda-Interferons and the single nucleotide polymorphisms: A milestone to tailor-made therapy for chronic hepatitis C.
Pages
« first
‹ previous
…
68
69
70
71
72
73
74
75
76
…
next ›
last »